ProfileGDS4718 / 1554179_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 66% 67% 81% 71% 64% 67% 70% 72% 68% 68% 65% 61% 69% 66% 70% 63% 65% 65% 65% 67% 74% 66% 65% 68% 67% 68% 68% 64% 59% 69% 66% 67% 66% 68% 65% 63% 67% 74% 69% 75% 67% 65% 68% 66% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5289666
GSM549102patient 115, normal, homogenized [OPG study]6.6505167
GSM549104patient 119, normal, homogenized [OPG study]7.9995281
GSM549108patient 138, normal, homogenized [OPG study]6.8799471
GSM549119patient 077, normal, homogenized [OPG study]6.4227964
GSM549133patient 032, cancer, homogenized [OPG study]6.6347667
GSM549139patient 042, cancer, homogenized [OPG study]6.8530270
GSM549099patient 107, normal, homogenized [OPG study]7.0009372
GSM549109patient 139, normal, homogenized [OPG study]6.6830668
GSM549110patient 046, normal, homogenized [OPG study]6.6567868
GSM549114patient 063, normal, homogenized [OPG study]6.4156365
GSM549122patient 082, normal, homogenized [OPG study]6.1977961
GSM549134patient 033, cancer, homogenized [OPG study]6.7607569
GSM549136patient 036, cancer, homogenized [OPG study]6.5922766
GSM549140patient 044, cancer, homogenized [OPG study]6.8932270
GSM549111patient 047, normal, homogenized [OPG study]6.3511463
GSM549113patient 057, normal, homogenized [OPG study]6.4922665
GSM549132patient 031, cancer, homogenized [OPG study]6.4698665
GSM549137patient 038, cancer, homogenized [OPG study]6.5251465
GSM549142patient 047, cancer, homogenized [OPG study]6.6702267
GSM549100patient 110, normal, homogenized [OPG study]7.1591374
GSM549107patient 135, normal, homogenized [OPG study]6.5587466
GSM549115patient 068, normal, homogenized [OPG study]6.4871765
GSM549116patient 072, normal, homogenized [OPG study]6.7211968
GSM549120patient 078, normal, homogenized [OPG study]6.6667
GSM549131patient 030, cancer, homogenized [OPG study]6.7102968
GSM549118patient 074, normal, homogenized [OPG study]6.7473668
GSM549129patient 027, cancer, homogenized [OPG study]6.4217464
GSM549123patient 088, normal, homogenized [OPG study]6.0613659
GSM549124patient 006, cancer, homogenized [OPG study]6.7764169
GSM549126patient 015, cancer, homogenized [OPG study]6.5547766
GSM549128patient 025, cancer, homogenized [OPG study]6.6516167
GSM549103patient 117, normal, homogenized [OPG study]6.5147766
GSM549117patient 073, normal, homogenized [OPG study]6.6483368
GSM549138patient 041, cancer, homogenized [OPG study]6.4879665
GSM549141patient 045, cancer, homogenized [OPG study]6.3940563
GSM549130patient 028, cancer, homogenized [OPG study]6.6546167
GSM549101patient 111, normal, homogenized [OPG study]7.2097574
GSM549105patient 128, normal, homogenized [OPG study]6.7851369
GSM549106patient 134, normal, homogenized [OPG study]7.4449775
GSM549112patient 048, normal, homogenized [OPG study]6.6199867
GSM549125patient 011, cancer, homogenized [OPG study]6.4635765
GSM549127patient 024, cancer, homogenized [OPG study]6.780868
GSM549135patient 035, cancer, homogenized [OPG study]6.5690866